IL-1 receptor antagonist in sepsis: new findings with old data?

Affiliations

Editorial

David Grimaldi et al. J Thorac Dis. 2016 Sep.

. 2016 Sep;8(9):2379-2382.

doi: 10.21037/jtd.2016.08.51.

¹ Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Bruxelles, Belgium.

No abstract available

Conflict of interest statement

The authors have no conflicts of interest to declare.

Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial.
Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, Cron RQ, Opal SM. Shakoory B, et al. Crit Care Med. 2016 Feb;44(2):275-81. doi: 10.1097/CCM.0000000000001402. Crit Care Med. 2016. PMID: 26584195 Free PMC article. Clinical Trial.

1. Shakoory B, Carcillo JA, Chatham WW, et al. Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial. Crit Care Med 2016;44:275-81. 10.1097/CCM.0000000000001402 - DOI - PMC - PubMed
1. Opal SM, Fisher CJ, Jr, Dhainaut JF, et al. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med 1997;25:1115-24. 10.1097/00003246-199707000-00010 - DOI - PubMed
1. Fisher CJ, Jr, Slotman GJ, Opal SM, et al. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. Crit Care Med 1994;22:12-21. 10.1097/00003246-199401000-00008 - DOI - PubMed
1. Fisher CJ, Jr, Dhainaut JF, Opal SM, et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA 1994;271:1836-43. 10.1001/jama.1994.03510470040032 - DOI - PubMed
1. Dinarello CA, van der Meer JW. Treating inflammation by blocking interleukin-1 in humans. Semin Immunol 2013;25:469-84. 10.1016/j.smim.2013.10.008 - DOI - PMC - PubMed